RECENT FEATURE ARTICLES
Celebrating its 10th anniversary, the theme for this year’s EBME (Electronic and biomedical engineering) conference and exhibition was how the latest healthcare technology can improve patient outcomes. Over two days, a broad range of speakers shared fascinating insight into the future of healthcare.
The NHS wants to be the safest healthcare system in the world – that is its stated aim. As we wait to hear the results of a public consultation 1 with a strategy designed to sit alongside the NHS Long Term Plan, Kate Woodhead RGN DMS, analyses the challenges facing the patient safety movement.
Cleaning is critical for sterilisation to be effective; this has been well proven and does not require further evidencing. However, warns Pawel de Sternberg Stojalowski, founder and managing director at decontamination specialist Aseptium, the complexity of the cleaning process itself, measuring the effectiveness and the quality of cleaning is quite another matter.
While hospital Trusts want to save money on chemistries, this must be balanced with ensuring efficacy and patient safety at all times. With cheap chemistries entering the market, is it time for a national register to ensure clarity around performance? Moreover, how could new technologies help optimise decontamination chemistries and provide a tool for improvement? Matthew Peskett, from Ruhof, speaks to CSJabout recent trends and controversies.
Decontamination of reusable medical devices including ultrasound probes is important to prevent infection transmission. The number of ultrasound procedures is rapidly increasing and, according to Jon Burdach, PhD, head of clinical affairs at Nanosonics, the need to keep up-to-date on decontamination requirements may be challenging for some ultrasound users.
Dennis Fitzpatrick, University of West London; Andrew Barton, Frimley Park Hospital, and Keith Pamment, City University, London, discuss a port location device that has been designed to improve first attempt port access, and to minimise the risk of subcutaneous infection andpain that a patient experiences with subsequent needle insertion attempts.
Hair loss is a well-known side effect of many chemotherapy regimens, with many patients claiming it is the most traumatic aspect of their treatment. Now, the world’s first scalp cooling research centre is committed to achieving its vision of ‘zero hair loss’ during chemotherapy.
The Topol Review, an independent report on behalf of the Secretary of State for Health and Social Care, was released on 11 February 2019, outlining the usage of digital technology within Trusts across the UK. CSJ examines what this means for the future of healthcare and NHS staff.
A new purpose-built operating theatre has been completed, offering a world-class training and demonstration base for customers to experience Bender UK technology first-hand. The Clinical Services Journalpaid a visit to this remarkable operating theatre demonstration room.